[Kosdaq Star] Explosive growth of Hugel attracts foreign funds
Aug 22, 2016
Hugel, a runner-up in the Botulinum toxin market, was in the spotlight last week, as it attracted the largest funds from foreign investors on the Kosdaq this year. According to a report by the Korea Exchange, the pharmaceutical firm received a total of 202.2 billion won ($181 million) in foreign investments as of Aug. 10, marking its rise as a new Kosdaq star. The company’s share price jumped from 180,100 won in late 2015 to 439,900 won as of Friday. Its stocks were flying high Friday as investo